推荐产品
化驗
97%
形狀
crystals
mp
144-148 °C (lit.)
SMILES 字串
O=C1C(c2ccccc2)C(=O)c3ccccc13
InChI
1S/C15H10O2/c16-14-11-8-4-5-9-12(11)15(17)13(14)10-6-2-1-3-7-10/h1-9,13H
InChI 密鑰
NFBAXHOPROOJAW-UHFFFAOYSA-N
基因資訊
human ... VKORC1(79001)
正在寻找类似产品? 访问 产品对比指南
訊號詞
Danger
危險聲明
危險分類
Acute Tox. 3 Oral - Skin Sens. 1
儲存類別代碼
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
水污染物質分類（WGK）
WGK 3
閃點（°F）
Not applicable
閃點（°C）
Not applicable
個人防護裝備
Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges
P Gelot et al.
Annales de dermatologie et de venereologie, 139(4), 282-286 (2012-04-10)
Antiphospholipid syndrome (APS) is characterised by arterial or venous thrombosis combined with the presence of specific antibodies known as antiphospholipids. It is commonly associated with cutaneous signs. Herein we report a case of atypical cutaneous eruption occurring during the course
Gérard Cam et al.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 27(4), 1554-1558 (2011-09-21)
Among the vitamin K antagonists (VKA), indanedione-derived VKA is suspected to induce an immunoallergic risk. One indanedione-derived VKA, fluindione, is still being used in France. The aim of this study was to evaluate the contribution of VKA to acute and
Amélie Daveluy et al.
European journal of clinical pharmacology, 68(1), 101-105 (2011-07-28)
Fluindione is an oral vitamin K antagonist (indanedione derivative) exclusively marketed in France and Luxembourg, known to have immuno-allergic adverse effects such as hepatitis, fever or interstitial nephritis. A few cases of drug reaction with eosinophilia and systemic symptoms (DRESS)
C Merklen-Djafri et al.
Annales de dermatologie et de venereologie, 139(3), 199-203 (2012-03-10)
Cutaneous necrosis is a rare complication of vitamin K antagonist therapy. It presents as cutaneous hemorrhagic necrosis and usually occurs at the start of treatment. We describe an atypical case of recurrent skin necrosis after two years of treatment with
"Fulminant" Behçet disease.
Mohamad Zaidan et al.
Presse medicale (Paris, France : 1983), 40(11), 1087-1089 (2011-06-11)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门